We are live on
!
Find out more
BOCH
Blue Owl Capital Holdings Portfolio holdings
AUM
$372M
1-Year Est. Return
78.25%
This Fund
S&P 500
This Quarter
Est. Return
-13.86%
1 Year Est. Return
+78.25%
3 Year Est. Return
+112.77%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$310M
AUM Growth
-$124M
(-29%)
Cap. Flow
-$12.5M
Cap. Flow
% of AUM
-4.04%
Top 10 Holdings %
Top 10 Hldgs %
68.81%
Holding
86
New
8
Increased
20
Reduced
4
Closed
13
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
ProShares UltraPro QQQ
TQQQ
|
+$13.3M |
| 2 |
Civeo
CVEO
|
+$8.13M |
| 3 |
Holley
HLLY
|
+$6.53M |
| 4 |
CMPS
Compass Pathways
CMPS
|
+$3.74M |
| 5 |
NextNav
NN
|
+$2.4M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Klaviyo
KVYO
|
+$44.5M |
| 2 |
SLRN
ACELYRIN
SLRN
|
+$8.74M |
| 3 |
MREO
Mereo BioPharma
MREO
|
+$2.35M |
| 4 |
PVLA
Palvella Therapeutics
PVLA
|
+$2.12M |
| 5 |
GOCO
GoHealth
GOCO
|
+$888K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 44.2% |
| 2 | Financials | 32.56% |
| 3 | Technology | 12.36% |
| 4 | Consumer Discretionary | 6.99% |
| 5 | Energy | 0.34% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
76
Klaviyo
KVYO
$5.09B
| – | – |
-1,078,770
| Closed | -$44.5M |
|
|
MREO
77
Mereo BioPharma
MREO
$43.5M
| – | – |
-672,809
| Closed | -$2.35M |
|
78
Syntec Optics
OPTX
$305M
| – | – |
-49,575
| Closed | -$125K |
|
|
SATX
79
DELISTED
SatixFy Communications
SATX
| – | – |
-50,794
| Closed | -$77.7K |
|
|
SLRN
80
DELISTED
ACELYRIN
SLRN
| – | – |
-2,783,946
| Closed | -$8.74M |
|
|
NKGNW
81
DELISTED
NKGen Biotech, Inc. Warrants
NKGNW
| – | – |
-30,000
| Closed | -$3K |
|
|
OMGA
82
DELISTED
Omega Therapeutics, Inc. Common Stock
OMGA
| – | – |
-1,055,882
| Closed | -$787K |
|
|
BYNOW
83
DELISTED
byNordic Acquisition Corporation Warrant
BYNOW
| – | – |
-516,185
| Closed | -$20.6K |
|
|
BYNO
84
DELISTED
byNordic Acquisition Corporation Class A Common Stock
BYNO
| – | – |
-91,429
| Closed | -$549 |
|
|
PLMJW
85
DELISTED
Plum Acquisition Corp. III Warrant
PLMJW
| – | – |
-1,166,665
| Closed | -$220K |
|
|
PLMJU
86
DELISTED
Plum Acquisition Corp. III Unit
PLMJU
| – | – |
-15,000
| Closed | -$94.6K |
|
Similar funds
PC
GIP
DPCM
SAAM
KP
TCM
JC
HPC
Blue Owl Capital Holdings's Q1 2025 Portfolio in Review
As of Q1 2025, Blue Owl Capital Holdings held 86 positions worth $310M, down 29% from $434M the previous quarter. Its ten largest holdings account for 69% of the portfolio.
Blue Owl Capital Holdings withdrew a net $12.5M in Q1 2025, closing 13 positions and reducing 4 holdings. Its most notable exit was Klaviyo, an estimated $44.5M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 44% of assets, down from 51% a quarter earlier, followed by Financials and Technology.
Against the trend, Blue Owl Capital Holdings opened a new position in ProShares UltraPro QQQ worth $10M.
- Blue Owl Capital Holdings's largest Q1 2025 buy was ProShares UltraPro QQQ: 350,000 shares worth $10M.
- Blue Owl Capital Holdings added most to Holley in Q1 2025, an estimated $6.53M increase.
- Blue Owl Capital Holdings's biggest Q1 2025 reduction was Palvella Therapeutics, cutting an estimated $2.12M.
- Blue Owl Capital Holdings fully exited Klaviyo in Q1 2025, selling an estimated $44.5M.
- Blue Owl Capital Holdings's ten largest holdings make up 69% of its $310M portfolio in Q1 2025.
- Blue Owl Capital Holdings opened 8 new positions and closed 13 in Q1 2025.
- Blue Owl Capital Holdings's portfolio value fell 29% quarter-over-quarter to $310M.
Based on Blue Owl Capital Holdings's 13F filing for Q1 2025, filed 15 May 2025.